Cardiovascular Research in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Cardiovascular Research in Brazil

Cardiovascular Research in Brazil – Clinical Trials in Latin America

Cardiovascular diseases (CVDs) pose a significant global health burden, and Brazil is no exception. However, Brazil has emerged as a leader in cardiovascular research, making significant strides in understanding, preventing, and treating these conditions.

This blog explores the pioneering cardiovascular research initiatives taking place in Brazil, highlighting the nation’s commitment to improving heart health. From groundbreaking studies to innovative treatments and collaborative efforts,

Brazil’s advancements in cardiovascular research are shaping the future of cardiovascular medicine and making a profound impact on the nation’s health.

Research Landscape

Brazil boasts a vibrant research landscape in cardiovascular health, with renowned institutions dedicated to cardiovascular research and treatment. The Brazilian Society of Cardiology, the National Institute of Cardiology, and leading universities and hospitals serve as catalysts for innovation and collaboration.

These institutions nurture a conducive environment for researchers, clinicians, and scientists to tackle the complex challenges associated with cardiovascular diseases.

Epidemiological Studies

Brazil has conducted extensive epidemiological studies to understand the burden of cardiovascular diseases and associated risk factors. Large-scale national surveys, such as the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), provide valuable insights into the prevalence, incidence, and regional variations of CVDs across the country.

These studies have contributed to identifying risk factors like obesity, hypertension, diabetes, and lifestyle behaviors, shaping targeted interventions and public health strategies to mitigate the impact of cardiovascular diseases.

Genetic Research

Brazilian researchers have made significant contributions to genetic research in cardiovascular diseases. Through collaborative studies, genome-wide association studies, and genetic sequencing projects, scientists have identified genetic variants associated with various cardiovascular conditions, including arrhythmias, familial hypercholesterolemia, and cardiomyopathies.

These findings have implications for personalized medicine, risk stratification, and the development of targeted therapies tailored to the Brazilian population.

Cardiovascular Research in Brazil

Cardiovascular Research in Brazil

Cardiovascular Research in Brazil

Technological Advancements and Innovations

Brazil is at the forefront of technological advancements and innovations in cardiovascular research and treatment. From state-of-the-art cardiac imaging techniques to the development of novel medical devices and telemedicine applications, Brazilian researchers and healthcare professionals are leveraging technology to improve patient outcomes and enhance accessibility to specialized care.

These innovations have played a crucial role in early diagnosis, minimally invasive interventions, and improved long-term management of cardiovascular conditions.

Clinical Trials and Translational Research

Brazil actively participates in clinical trials and translational research, contributing to the global body of evidence in cardiovascular medicine. Collaborative efforts between academic institutions, clinical centers, and pharmaceutical companies have enabled the conduct of multicenter trials, evaluating new therapies, interventions, and diagnostic tools.

By actively engaging in clinical research, Brazil is at the forefront of evidence-based practice, ensuring that patients receive the most effective and tailored treatments.

Public Health Initiatives and Prevention Programs

Brazil places a strong emphasis on public health initiatives and prevention programs to combat cardiovascular diseases. National campaigns, community outreach programs, and educational efforts aim to raise awareness about cardiovascular risk factors, promote healthy lifestyles, and encourage early detection.

Government policies support the implementation of preventive measures such as tobacco control, salt reduction, and physical activity promotion. These comprehensive approaches prioritize the reduction of modifiable risk factors and empower individuals to take charge of their cardiovascular health.


Brazil’s unwavering commitment to cardiovascular research has positioned the country as a global leader in the field. Through a robust research landscape, epidemiological studies, genetic research, technological advancements, clinical trials, and public health initiatives, Brazil is spearheading efforts to advance cardiovascular medicine and improve heart health for all its citizens.

These endeavors not only contribute to scientific knowledge but also have a tangible impact on the health and well-being of the Brazilian population. By focusing on prevention, early detection, and cutting-edge treatments, Brazil is actively working towards reducing the burden of cardiovascular diseases and improving patient outcomes.

Furthermore, Brazil’s collaborative approach, both within the country and on the global stage, fosters knowledge exchange, research partnerships, and the sharing of best practices.

Collaborations with international organizations, such as the World Heart Federation and the Pan American Health Organization, strengthen Brazil’s research capacity and enable the country to contribute to global efforts in combating cardiovascular diseases.

Cardiovascular Research in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Cardiovascular Research in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Cardiovascular Research in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Cardiovascular Research in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Cardiovascular Research in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Cardiovascular Research in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Cardiovascular Research in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Cardiovascular Research in Brazil

The Cohortias Team

Cardiovascular Research in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Cardiovascular Research in Brazil

Network & Partnerships